Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

NCT02430350 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Compound Edaravone Injection
DRUG: Edaravone Injection

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.